目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Discovery Outsourcing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Premium Insights
3.1 Geographical Snapshot: Global Drug Discovery Outsourcing Market
3.2 Service Type Segment: Market Attractiveness Index
3.3 Molecule Type Segment: Market Attractiveness Index
3.4 Therapeutic Area Segment: Market Attractiveness Index

4 Market Overview
4.1 Market Dynamics
4.1.1 Market Driving Factors
4.1.2 Market Restraining Factors
4.1.3 Market Opportunities
4.2 COVID-19 Impact Analysis
4.3 R&D Outsourcing Business Model (Fee-for-Service)
4.4 Collaborations Between CRO and Pharmaceutical Industry
4.5 Porter’s Five Forces Analysis
4.5.1 Competitive Rivalry: High
4.5.2 Threat of Substitutes: Medium
4.5.3 Bargaining Power of Buyer: High
4.5.4 Bargaining Power of Suppliers: Medium
4.5.5 Threat of New Entrants: Medium

5 Global Drug Discovery Outsourcing Market Analysis by Service Type
5.1 Key Findings
5.2 Service Type Segment Growth Prospects
5.3 Global Drug Discovery Outsourcing Market Size Estimation and Forecast by Service Type
5.4 Chemical Services
5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Biology Services
5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Lead Optimization
5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
5.7 Lead Identification & Screening
5.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Market Share by Region, 2022 & 2032 (%)
5.8 Others
5.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.8.2 Market Share by Region, 2022 & 2032 (%)

6 Global Drug Discovery Outsourcing Market Analysis by Molecule Type
6.1 Key Findings
6.2 Molecule Type Segment Growth Prospects
6.3 Global Drug Discovery Outsourcing Market Size Estimation and Forecast by Molecule Type
6.4 Large Molecule Drugs
6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.4.3 Market Forecast by Type, 2022-2032 (US$ Mn)
6.5 Small Molecule Drugs
6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Market Share by Region, 2022 & 2032 (%)

7 Global Drug Discovery Outsourcing Market Analysis by Therapeutic Area
7.1 Key Findings
7.2 Therapeutic Area Segment Growth Prospects
7.3 Global Drug Discovery Outsourcing Market Size Estimation and Forecast by Therapeutic Area
7.4 Oncology
7.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Infectious Disease
7.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Central Nervous System
7.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Immunology
7.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Cardiovascular Disease
7.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Metabolic Disease
7.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.9.2 Market Share by Region, 2022 & 2032 (%)
7.10 Respiratory Disease
7.10.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.10.2 Market Share by Region, 2022 & 2032 (%)
7.11 Others
7.11.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.11.2 Market Share by Region, 2022 & 2032 (%)

8 Global Drug Discovery Outsourcing Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

9 North America Drug Discovery Outsourcing Market Analysis
9.1 Key Findings
9.2 North America Drug Discovery Outsourcing Market Attractiveness Index
9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
9.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
9.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
9.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
9.8 U.S.
9.9 Canada

10 Europe Drug Discovery Outsourcing Market Analysis
10.1 Key Findings
10.2 Europe Drug Discovery Outsourcing Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
10.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
10.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
10.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
10.8 Germany
10.9 UK
10.10 France
10.11 Italy
10.12 Spain
10.13 Russia
10.14 Rest of Europe

11 Asia Pacific Drug Discovery Outsourcing Market Analysis
11.1 Key Findings
11.2 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
11.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
11.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
11.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
11.8 Japan
11.9 China
11.10 India
11.11 Australia
11.12 South Korea
11.13 Rest of Asia Pacific

12 Latin America Drug Discovery Outsourcing Market Analysis
12.1 Key Findings
12.2 Latin America Drug Discovery Outsourcing Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
12.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
12.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
12.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
12.8 Brazil
12.9 Mexico
12.10 Rest of Latin America

13 MEA Drug Discovery Outsourcing Market Analysis
13.1 Key Findings
13.2 MEA Drug Discovery Outsourcing Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
13.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
13.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
13.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
13.8 GCC
13.9 South Africa
13.10 Rest of MEA

14 Company Profiles
14.1 Curia Global, Inc.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Product Benchmarking
14.2 Charles River Laboratories
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Dalton Pharma
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.3.4 Strategic Outlook
14.4 Domainex
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Strategic Outlook
14.5 Eurofins
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Evotec AG
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Genscript
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Jubilant Biosys Ltd.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Laboratory Corporation of America Holdings
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Pharmaron
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 QIAGEN N.V.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Selvita
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Sundia Meditech Co Ltd.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Sygnature Discovery
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.15.4 Strategic Outlook
14.16 Syngene International
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Thermo Fisher Scientific Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.17.5 Strategic Outlook
14.18 WuXi AppTec
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Global Drug Discovery Outsourcing Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 Global Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 7 Chemical Services Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 8 Biology Services Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 9 Lead Optimization Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 10 Lead Identification & Screening Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 12 Global Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 13 Large Molecule Drugs Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 14 Large Molecule Drugs Market Forecast by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 15 Small Molecule Drugs Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 16 Global Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 17 Oncology Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 18 Infectious Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 19 Central Nervous System Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 20 Immunology Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 21 Cardiovascular Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 22 Metabolic Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 23 Respiratory Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 25 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 26 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 27 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 28 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 29 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 North America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 31 North America Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 32 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 33 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 34 U.S. Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 35 Canada Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 36 Europe Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 37 Europe Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 38 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 39 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 40 Germany Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 41 UK Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 42 France Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 43 Italy Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 44 Spain Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 45 Russia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 46 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 47 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 48 Asia Pacific Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 49 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 50 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 51 Japan Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 52 China Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 53 India Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 54 Australia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 55 South Korea Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 56 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 57 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 58 Latin America Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 59 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 60 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 61 Brazil Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 62 Mexico Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 63 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 64 MEA Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 65 MEA Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 66 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 67 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 68 GCC Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 69 South Africa Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 70 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 71 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Curia Global, Inc.: Product Benchmarking
Table 73 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Charles River Laboratories: Product Benchmarking
Table 75 Charles River Laboratories: Strategic Outlook
Table 76 Dalton Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Dalton Pharma: Product Benchmarking
Table 78 Dalton Pharma: Strategic Outlook
Table 79 Domainex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Domainex: Product Benchmarking
Table 81 Domainex: Strategic Outlook
Table 82 Eurofins: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Eurofins: Product Benchmarking
Table 84 Eurofins: Strategic Outlook
Table 85 Evotec AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Evotec AG: Product Benchmarking
Table 87 Evotec AG: Strategic Outlook
Table 88 Genscript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Genscript: Product Benchmarking
Table 90 Genscript: Strategic Outlook
Table 91 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Product Benchmarking
Table 93 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Strategic Outlook
Table 94 Jubilant Biosys Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Jubilant Biosys Ltd.: Product Benchmarking
Table 96 Jubilant Biosys Ltd.: Strategic Outlook
Table 97 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Laboratory Corporation of America Holdings: Product Benchmarking
Table 99 Laboratory Corporation of America Holdings: Strategic Outlook
Table 100 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Pharmaron: Product Benchmarking
Table 102 Pharmaron: Strategic Outlook
Table 103 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 QIAGEN N.V.: Product Benchmarking
Table 105 QIAGEN N.V.: Strategic Outlook
Table 106 Selvita: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Selvita: Product Benchmarking
Table 108 Selvita: Strategic Outlook
Table 109 Sundia Meditech Co Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Sundia Meditech Co Ltd.: Product Benchmarking
Table 111 Sygnature Discovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Sygnature Discovery: Product Benchmarking
Table 113 Sygnature Discovery: Strategic Outlook
Table 114 Syngene International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Syngene International: Product Benchmarking
Table 116 Syngene International: Strategic Outlook
Table 117 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 119 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 120 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 WuXi AppTec: Product Benchmarking
Table 122 WuXi AppTec: Strategic Outlook
?

List of Figures
Figure 1 Global Drug Discovery Outsourcing Market Segmentation
Figure 2 Global Drug Discovery Outsourcing Market Attractiveness Index by Region
Figure 3 Global Drug Discovery Outsourcing Market by Service Type: Market Attractiveness Index
Figure 4 Global Drug Discovery Outsourcing Market by Molecule Type: Market Attractiveness Index
Figure 5 Global Drug Discovery Outsourcing Market by Therapeutic Area: Market Attractiveness Index
Figure 6 Global Drug Discovery Outsourcing Market: Market Dynamics
Figure 7 Global COVID Impact Analysis: Drug Discovery Outsourcing Market Recovery Scenarios
Figure 8 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Global Drug Discovery Outsourcing Market: Porter’s Five Forces Analysis
Figure 13 Global Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 14 Global Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 15 Global Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022, 2027, 2032 (%)
Figure 16 Chemical Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 17 Chemical Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 18 Biology Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 19 Biology Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Lead Optimization Market Forecast by Region, 2022-2032 (US$ million)
Figure 21 Lead Optimization Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Lead Identification & Screening Market Forecast by Region, 2022-2032 (US$ million)
Figure 23 Lead Identification & Screening Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Global Drug Discovery Outsourcing Market Attractiveness Index by Molecule Type
Figure 27 Global Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 28 Global Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022, 2027, 2032 (%)
Figure 29 Large Molecule Drugs Market Forecast by Region, 2022-2032 (US$ million)
Figure 30 Large Molecule Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 31 Large Molecule Drugs Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Small Molecule Drugs Market Forecast by Region, 2022-2032 (US$ million)
Figure 33 Small Molecule Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 34 Global Drug Discovery Outsourcing Market Attractiveness Index by Therapeutic Area
Figure 35 Global Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 36 Global Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022, 2027, 2032 (%)
Figure 37 Oncology Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Oncology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Infectious Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Infectious Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Central Nervous System Market Forecast by Region, 2022-2032 (US$ million)
Figure 42 Central Nervous System Market Share Forecast by Region, 2022 & 2032 (%)
Figure 43 Immunology Market Forecast by Region, 2022-2032 (US$ million)
Figure 44 Immunology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 45 Cardiovascular Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 46 Cardiovascular Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 47 Metabolic Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 48 Metabolic Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 Respiratory Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 50 Respiratory Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 52 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 53 Global Drug Discovery Outsourcing Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 54 Global Drug Discovery Outsourcing Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 55 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Figure 56 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 57 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 58 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 59 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 60 North America Drug Discovery Outsourcing Market Attractiveness Index
Figure 61 North America Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 62 North America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 63 North America Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 64 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 65 North America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 66 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 67 North America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 68 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 69 North America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 70 U.S. Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 71 Canada Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 72 Europe Drug Discovery Outsourcing Market Attractiveness Index
Figure 73 Europe Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 74 Europe Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 75 Europe Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 76 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 77 Europe Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 78 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 79 Europe Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 80 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 81 Europe Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 82 Germany Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 83 UK Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 84 France Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 85 Italy Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 86 Spain Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 87 Russia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 88 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 89 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
Figure 90 Asia Pacific Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 91 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 92 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 93 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 94 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 95 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 96 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 97 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 98 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 99 Japan Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 100 China Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 101 India Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 102 Australia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 103 South Korea Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 104 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 105 Latin America Drug Discovery Outsourcing Market Attractiveness Index
Figure 106 Latin America Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 107 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 108 Latin America Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 109 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 110 Latin America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 111 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 112 Latin America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 113 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 114 Latin America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 115 Brazil Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 116 Mexico Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 117 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 118 MEA Drug Discovery Outsourcing Market Attractiveness Index
Figure 119 MEA Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 120 MEA Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 121 MEA Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 122 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 123 MEA Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 124 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 125 MEA Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 126 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 127 MEA Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 128 GCC Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 129 South Africa Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 130 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 131 Charles River Laboratories: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 132 Charles River Laboratories: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 133 Eurofins: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 134 Eurofins: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 135 Evotec AG: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 136 Evotec AG: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 137 Evotec AG: R&D, 2015-2021 (US$ million, AGR%)
Figure 138 Genscript: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 139 Jubilant Biosys Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 140 Laboratory Corporation of America Holdings: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 141 Laboratory Corporation of America Holdings: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 142 Pharmaron: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 143 QIAGEN N.V.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 144 QIAGEN N.V.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 145 QIAGEN N.V.: R&D, 2015-2021 (US$ million, AGR%)
Figure 146 Syngene International: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 147 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 148 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 149 Thermo Fisher Scientific Inc.: R&D, 2015-2021 (US$ million, AGR%)
Figure 150 WuXi AppTec: Net Revenue, 2015-2021 (US$ million, AGR%)